000 01493 a2200409 4500
005 20250514051033.0
264 0 _c20030429
008 200304s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/dkf204
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbrescia, Nicola
245 0 0 _aFulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cNov 2002
300 _a763-5 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAcquired Immunodeficiency Syndrome
_xcomplications
650 0 4 _aAdult
650 0 4 _aAlkynes
650 0 4 _aAntiretroviral Therapy, Highly Active
_xadverse effects
650 0 4 _aBenzoxazines
650 0 4 _aCyclopropanes
650 0 4 _aFemale
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHepatitis, Viral, Human
_xcomplications
650 0 4 _aHumans
650 0 4 _aLiver Failure
_xchemically induced
650 0 4 _aOxazines
_xadverse effects
700 1 _aD'Abbraccio, Maurizio
700 1 _aFigoni, Mario
700 1 _aBusto, Annunziata
700 1 _aButrico, Ettore
700 1 _aDe Marco, Mario
700 1 _aViglietti, Rosaria
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 50
_gno. 5
_gp. 763-5
856 4 0 _uhttps://doi.org/10.1093/jac/dkf204
_zAvailable from publisher's website
999 _c12215415
_d12215415